SCOPUS ASSET MANAGEMENT, L.P. - SYNTHETIC BIOLOGICS INC ownership

SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U201. A total of 25 filers reported holding SYNTHETIC BIOLOGICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SCOPUS ASSET MANAGEMENT, L.P. ownership history of SYNTHETIC BIOLOGICS INC
ValueSharesWeighting
Q3 2020$107,000
-7.0%
225,0000.0%0.00%
-33.3%
Q2 2020$115,000
+59.7%
225,0000.0%0.00%
-50.0%
Q1 2020$72,000
-36.8%
225,0000.0%0.01%
+50.0%
Q4 2019$114,000
+11.8%
225,0000.0%0.00%
+33.3%
Q3 2019$102,000
-17.7%
225,0000.0%0.00%
-25.0%
Q2 2019$124,000
-19.0%
225,0000.0%0.00%0.0%
Q1 2019$153,000
+21.4%
225,0000.0%0.00%
-50.0%
Q4 2018$126,000
-78.7%
225,000
-1.3%
0.01%0.0%
Q3 2018$592,000227,8600.01%
Other shareholders
SYNTHETIC BIOLOGICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
MSD Partners, L.P. 960,680$655,0000.02%
Virtu Financial LLC 466,704$318,0000.02%
tru Independence LLC 60,000$30,0000.01%
Jacobi Capital Management LLC 18,500$13,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 109,300$75,0000.00%
Focused Wealth Management, Inc 500$00.00%
UBS Group AG 576,927$393,0000.00%
Stratos Wealth Partners, LTD. 10,850$7,0000.00%
NewEdge Advisors, LLC 14,187$10,0000.00%
Sowell Financial Services LLC 74$00.00%
View complete list of SYNTHETIC BIOLOGICS INC shareholders